Expanding the armamentarium for the treatment of Clostridium difficile infection
- PMID: 28461208
- DOI: 10.1016/S1473-3099(17)30237-2
Expanding the armamentarium for the treatment of Clostridium difficile infection
Comment on
-
Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study.Lancet Infect Dis. 2017 Jul;17(7):735-744. doi: 10.1016/S1473-3099(17)30235-9. Epub 2017 Apr 28. Lancet Infect Dis. 2017. PMID: 28461207 Free PMC article. Clinical Trial.
Similar articles
-
Deadly diarrhea: Clostridium difficile infection.Nephrol Nurs J. 2012 Nov-Dec;39(6):459-68; quiz 469. Nephrol Nurs J. 2012. PMID: 23469412
-
[Fecal microbiota transplant in the treatment of recurrent Clostridium difficile infection: A case report].Rev Med Brux. 2016;37(3):174-177. Rev Med Brux. 2016. PMID: 28525191 French.
-
Clostridium difficile infection and intestinal microbiota interactions.Microb Pathog. 2015 Dec;89:201-9. doi: 10.1016/j.micpath.2015.10.018. Epub 2015 Nov 5. Microb Pathog. 2015. PMID: 26549493 Review.
-
Clostridium difficile infection in elderly nursing home residents.Anaerobe. 2014 Dec;30:184-7. doi: 10.1016/j.anaerobe.2014.08.007. Epub 2014 Aug 23. Anaerobe. 2014. PMID: 25152228 Review.
-
Clostridium difficile infection: current, forgotten and emerging treatment options.J Comp Eff Res. 2014 Sep;3(5):547-57. doi: 10.2217/cer.14.36. J Comp Eff Res. 2014. PMID: 25350805 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources